Dejani H, Eisen T D, Finkelstein F O
Department of Medicine and Nephrology, Hospital of St Raphael, New Haven, Connecticut, USA.
Am J Kidney Dis. 2000 Oct;36(4):752-8. doi: 10.1053/ajkd.2000.17654.
The incidence and prevalence of end-stage renal disease (ESRD), particularly in the elderly population, have continued to increase in the United States. It is estimated that 10% to 20% of the elderly patients with ESRD have potentially remediable renal vascular disease. The purpose of the present study is to examine the results of renal artery revascularization in 20 patients aged older than 55 years with chronic renal failure (serum creatinine level >2 mg/dL) with proximal renal artery stenosis (RAS) diagnosed by magnetic resonance angiography (MRA) who underwent surgical or percutaneous revascularization. Patients were followed up closely in the postrevascularization period; renal function was monitored and potential complications of the procedure were carefully noted. Four of the 20 patients developed serious complications, including 3 patients with clinically significant atheroembolic disease and 1 patient with renal artery dissection. Seven patients developed greater than 5% eosinophilia. Five of the 20 patients had a deterioration in renal function 3 to 6 months after the procedure, and only 5 patients had a reduction in serum creatinine concentration 3 to 6 months after the procedure. The present study suggests that in elderly patients with chronic renal failure and proximal RAS, revascularization of renal vessels is associated with a high complication rate, and improvement in renal function occurs in only 25% of the patients. Whether revascularization can slow the rate of progression of renal failure remains uncertain and can only be answered by a large prospective trial.
在美国,终末期肾病(ESRD)的发病率和患病率持续上升,尤其是在老年人群中。据估计,10%至20%的老年ESRD患者患有潜在可补救的肾血管疾病。本研究的目的是检查20例年龄大于55岁、患有慢性肾衰竭(血清肌酐水平>2mg/dL)且经磁共振血管造影(MRA)诊断为近端肾动脉狭窄(RAS)的患者接受手术或经皮血管重建术后的肾动脉重建结果。患者在血管重建术后接受密切随访;监测肾功能并仔细记录该手术的潜在并发症。20例患者中有4例出现严重并发症,包括3例患有具有临床意义的动脉粥样硬化栓塞疾病的患者和1例患有肾动脉夹层的患者。7例患者出现大于5%的嗜酸性粒细胞增多。20例患者中有5例在术后3至6个月出现肾功能恶化,术后3至6个月仅有5例患者血清肌酐浓度降低。本研究表明,在患有慢性肾衰竭和近端RAS的老年患者中,肾血管重建术的并发症发生率较高,只有25%的患者肾功能得到改善。肾血管重建术能否减缓肾衰竭的进展速度仍不确定,只能通过大型前瞻性试验来回答。